Test Code 2533B

Test Name Loperamide and Metabolite, Blood

Purpose
Abuse Monitoring
Method(s)
High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)
Suggested CPT Code(s)
80375
New York State Approval Status

Approved

Turnaround Time

8 days

Test Includes
1 Loperamide Imodium® High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5 Therapeutic opioid
2 Desmethylloperamide Loperamide Metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5 Inactive Metabolite

Compliance Statement
This test was developed and its performance characteristics determined by NMS Labs. It has not been cleared or approved by the US Food and Drug Administration.
Specimen Type
Blood
Requested Volume
2 mL
Minimum Volume
0.7 mL
Special Handling
None
Specimen Container
Gray top tube (Sodium Fluoride / Potassium Oxalate)

Additional Collection Instructions

Transport Temperature
Refrigerated
Light Protection
Not Required
Rejection Criteria
None

Rejection criteria pertain to clinical specimen submissions only.

Stability
Room Temperature: 14 day(s)
Refrigerated: 30 day(s)
Frozen (-20 °C): 24 month(s)
1 Loperamide Imodium® High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5 Therapeutic opioid
2 Desmethylloperamide Loperamide Metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5 Inactive Metabolite

Interface Map

LOINC® Information

The CPT Codes provided in this document are based on AMA Guidelines and are for informational purposes only. NMS Labs Does not assume responsibility for billing errors due to Reliance on the CPT Codes listed in this document.

*The information contained in this document represents database configurations, as they will appear on the effective date listed above.